Sunrise Realty Trust (NASDAQ:SUNS – Get Free Report) had its price objective dropped by Raymond James from $15.00 to $14.50 ...
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) was upgraded by Raymond James from an “outperform” rating to a “strong-buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results